On May 15, 2024, URGENT Medical Device Recall letters were sent to customers. Following identification of the affected lot units, please take the following action:
1. Please discontinue use and quarantine any product from Lot 10114.
2. Return any unused units of test kit Lot 10114 to the company or discard them
immediately according to standard practice.
NOTE: For return of unused test kits please indicate so in the acknowledgement and
receipt form and Customer Support will contact you with further instructions. 3. Review previously obtained test results conducted with the affected lot and identify
populations at higher risk. Retest if necessary.
NOTE: If you require assistance in identifying samples tested using the affected lot
please indicate so in the acknowledgment and receipt form and we will be happy to
provide you with any necessary information.
4. If you are a distributor, please share this notification with any customer to whom the
product was shipped, or may have been shipped.
5. You are kindly requested to fill out the attached Acknowledgement and Receipt Form
and return it to Sight as soon as possible, and in any case no later than 30 days from
the date of this notification, via email, to
[email protected]. Please provide
the form even if you no longer have any product in inventory so that we can verify
that all affected product has been removed.
6. If you are required to notify your local authority please use this notification and notify Sight as soon as possible. We appreciate your time and apologize for any inconvenience this may have caused. Please
do not hesitate to reach out with any questions or feedback to Customer Support via the
following channels:
US Customers
[email protected]
Callback service (voicemail) +1-833-SIGHTDX (7444839 ext. 3)
Text +1 617 4105226
Partners (Distributors)
[email protected]
Callback service (voicemail) +44 0203 093 0772 (ext. 2)
Text +44 7449 063724
Customer Support is available Mon-Fri EST- 2:00AM-7:00